Clinical Trial: Transcriptomics Signature of Anti Vaccinia Memory B Cells
Study Status: Recruiting
Recruit Status: Unknown status
Study Type: Observational
Official Title: Transcriptomics Signature of Anti Vaccinia Memory B Cells in Healthy Individuals at a Short Time After Vaccination
Brief Summary: Analyse the transcriptomic signature of anti vaccinia memory B cells at a short time after vaccination as compared to the signature already established in long-lived memory B cells.
Detailed Summary:
Sponsor: Institut National de la Santé Et de la Recherche Médicale, France
Current Primary Outcome: signature of anti vaccinia long-lived memory B cells [ Time Frame: 12 months ]
Original Primary Outcome: Same as current
Current Secondary Outcome:
Original Secondary Outcome:
Information By: Institut National de la Santé Et de la Recherche Médicale, France
Dates:
Date Received: September 21, 2015
Date Started: September 2015
Date Completion: September 2016
Last Updated: September 29, 2015
Last Verified: May 2015